Skip to content
Open access · CC-BY via OpenAlex

Novel transcriptomic signatures associated with premature kidney allograft failure

Petra Hrubá, Jǐŕı Kléma, Anh Vu Le, Eva Girmanová, Petra Mrázová, Annick Massart, Dita Maixnerová, Luděk Voska, Gian Benedetto Piredda, Luigi Biancone, Ana Ramírez Puga, Nurhan Seyahi, Mehmet Şükrü Sever, Laurent E. Weekers, Anja Muhfeld

EBioMedicine · 2023 · ▲ 8 citations

Abstract

BACKGROUND: The power to predict kidney allograft outcomes based on non-invasive assays is limited. Assessment of operational tolerance (OT) patients allows us to identify transcriptomic signatures of true non-responders for construction of predictive models. METHODS: In this observational retrospective study, RNA sequencing of peripheral blood was used in a derivation cohort to identify a protective set of transcripts by comparing 15 OT patients (40% females), from the TOMOGRAM Study (NCT05124444), 14 chronic active antibody-mediated rejection (CABMR) and 23 stable graft function patients ≥15 years (STA). The selected differentially expressed transcripts between OT and CABMR were used in a validation cohort (n = 396) to predict 3-year kidney allograft loss at 3 time-points using RT-qPCR. FINDINGS: Archetypal analysis and classifier performance of RNA sequencing data showed that OT is clearly distinguishable from CABMR, but similar to STA. Based on significant transcripts from the validation cohort in univariable analysis, 2 multivariable Cox models were created. A 3-transcript (ADGRG3, ATG2A, and GNLY) model from POD 7 predicted graft loss with C-statistics (C) 0.727 (95% CI, 0.638-0.820). Another 3-transcript (IGHM, CD5, GNLY) model from M3 predicted graft loss with C 0.786 (95% CI, 0.785-0.865). Combining 3-transcripts models with eGFR at POD 7 and M3 improved C-statistics to 0.860 (95% CI, 0.778-0.944) and 0.868 (95% CI, 0.790-0.944), respectively. INTERPRETATION: Identification of transcripts distinguishing OT from CABMR allowed us to construct models predicting premature graft loss. Identified transcripts reflect mechanisms of injury/repair and alloimmune response when assessed at day 7 or with a loss of protective phenotype when assessed at month 3. FUNDING: Supported by the Ministry of Health of the Czech Republic under grant NV19-06-00031.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.ebiom.2023.104782
Canonical
link ↗
Fetched
2026-11-16 MST

Cite this

APA
Hrubá, P., Kléma, J., Le, A.V., Girmanová, E., Mrázová, P., Massart, A., Maixnerová, D., Voska, L., Piredda, G.B., Biancone, L., Puga, A.R., Seyahi, N., Sever, M.�., Weekers, L.E., Muhfeld, A., Budde, K., Watschinger, B., Miglinas, M., Zahrádka, I., &amp; Abramowicz, M. (2023). Novel transcriptomic signatures associated with premature kidney allograft failure. <em>EBioMedicine</em>. https://doi.org/10.1016/j.ebiom.2023.104782
Vancouver
Hrubá P, Kléma J, Le AV, Girmanová E, Mrázová P, Massart A, et al. Novel transcriptomic signatures associated with premature kidney allograft failure. EBioMedicine. 2023. doi:10.1016/j.ebiom.2023.104782.
BibTeX
@article{petra2023Novelt, title = {Novel transcriptomic signatures associated with premature kidney allograft failure}, author = {Petra Hrubá and Jǐŕı Kléma and Anh Vu Le and Eva Girmanová and Petra Mrázová and Annick Massart and Dita Maixnerová and Luděk Voska and Gian Benedetto Piredda and Luigi Biancone and Ana Ramírez Puga and Nurhan Seyahi and Mehmet Şükrü Sever and Laurent E. Weekers and Anja Muhfeld and Klemens Budde and Bruno Watschinger and Marius Miglinas and Ivan Zahrádka and Marc Abramowicz and Daniel Abramowicz and Ondřej Viklický}, journal = {EBioMedicine}, year = {2023}, doi = {10.1016/j.ebiom.2023.104782}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings